|
|
 |
|
Viewing report
|
|
 |
 |
Company Financials: Zimmer Holdings, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Zimmer Holdings (Zimmer) is engaged in designing, developing, manufacturing, and marketing of orthopedic and dental reconstructive implants, spinal implants, trauma products and related orthopedic surgical products. It also offers healthcare related services.
Key reasons to purchase this title
- Includes information on revenue distribution by business segments and geographies
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Orthopedic Implants - A Global Market Overview
The Future of Orthopeadic Implants, Analysis and Forecasts to 2016 - Joint Reconstruction and Spinal Implants Creating Growth Opportunities
Orthopedics Markets
Global Orthopedics Devices Market (2011 – 2016)
Orthopedic Devices Market to 2017 - Spinal Surgery and Advanced Prosthetics Products to be Major Growth Driver
The Top 10 Orthopedic Device Companies: Financial Performance, Research Activities, and Growth Strategies
Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) - Greater Focus on Minimally Invasive Orthopedic Procedures to Drive the Market
Company Financials: Smith & Nephew plc
Worldwide Nanotechnology Dental Implant Market Shares, Strategies, and Forecasts, 2009 to 2015
Company Financials: BioMimetic Therapeutics, Inc.
|
 |
|
|